Whether you need estrogen, progesterone, or both depends primarily on two things: your symptoms and whether you still have a uterus. Most women going through menopause benefit from estrogen as the primary hormone for symptom relief, but if you have a uterus, you need progesterone alongside it to protect against uterine cancer. Women who’ve had a hysterectomy can typically use estrogen alone.
That’s the short answer. The longer answer involves understanding what each hormone actually does for your body, how to recognize which one you might be low in, and what the real risks look like with current evidence.
What Each Hormone Does for You
Estrogen is the heavier lifter when it comes to the symptoms most women associate with menopause. It’s the hormone responsible for relieving hot flashes, night sweats, vaginal dryness, sleep disturbances, and bone loss. When estrogen drops, you may also notice dry skin, difficulty concentrating, moodiness, weight gain around the belly, headaches, lower sex drive, and fatigue. These symptoms tend to be the ones that drive women to seek treatment in the first place.
Progesterone plays a different but important role. In premenopausal life, it regulates your cycle and prepares the uterine lining each month. During and after menopause, its main job in hormone therapy is protecting the uterus from the effects of estrogen. But progesterone also has benefits on its own: it acts on the brain to reduce anxiety and improve sleep quality. In a Canadian clinical trial, women taking oral progesterone reported significantly better sleep and fewer night sweats compared to those on a placebo. Animal research also suggests progesterone reduces inflammation and oxidative stress in the brain, though the human evidence for those effects is still developing.
Why Having a Uterus Changes the Answer
This is the most important factor in determining whether you need one hormone or both. Estrogen stimulates the uterine lining to grow. Without progesterone to counterbalance that growth, the lining can thicken abnormally, a condition called endometrial hyperplasia, which is a precursor to uterine cancer. Women who use estrogen alone for five or more years face at least double the risk of endometrial cancer, and some studies have documented a 10- to 30-fold increase with prolonged use.
Adding progesterone eliminates that excess risk entirely. In fact, combined estrogen-progesterone therapy actually reduces endometrial cancer risk by about 35% compared to taking no hormones at all. This is why every major medical organization, including ACOG, recommends that women with an intact uterus always pair estrogen with a progestin.
If you’ve had a hysterectomy, there’s no uterine lining to protect. Estrogen-only therapy is the standard approach, and it avoids the side effects that come with adding a second hormone.
How Symptoms Point Toward What You Need
Low estrogen and low progesterone can produce overlapping symptoms, but there are some distinguishing patterns. The classic estrogen-deficiency picture includes hot flashes, night sweats, vaginal dryness, and bone thinning. If those are your primary complaints, estrogen is doing most of the work to address them.
If your main issues are poor sleep, anxiety, and irregular or heavy periods (common in perimenopause, when estrogen can still be relatively high but progesterone drops first), progesterone may be the more targeted fix. During perimenopause, your ovaries become inconsistent. You may skip ovulation some months, which means you produce little to no progesterone that cycle, even while estrogen remains at near-normal levels. This imbalance can cause heavy bleeding, sleep disruption, and mood changes that respond well to progesterone on its own.
By the time you reach full menopause, both hormones have dropped significantly. At that point, most symptomatic women benefit from estrogen (with progesterone added if they have a uterus).
What Blood Tests Can Tell You
Blood work can help confirm where you are in the transition, though symptoms are often more useful than lab numbers for guiding treatment decisions. An FSH level above 30 mIU/mL is an objective marker of menopause, and levels above 40 IU/L correlate with the onset of hot flashes and night sweats. Estradiol levels below 20 pg/mL also suggest menopause.
These numbers are most helpful when your symptoms are ambiguous or when you’re young enough that premature menopause needs to be ruled out. For women in their late 40s and 50s with textbook symptoms, testing isn’t always necessary to start treatment.
Benefits Beyond Symptom Relief
Hormone therapy does more than manage discomfort. Randomized studies show that women who start hormone therapy within 10 years of menopause onset (generally before age 60) have lower rates of death from all causes and fewer fractures. The numbers are striking: cardiovascular disease risk may drop by as much as 50%, Alzheimer’s disease risk by 35%, and bone fracture risk by 50 to 60%.
These benefits are strongest when therapy begins in the early years of menopause rather than a decade or more later. Timing matters more than almost any other variable in determining whether hormone therapy helps or harms your cardiovascular system.
Risks Worth Understanding
The Women’s Health Initiative, a large trial from the early 2000s, shaped public fears about hormone therapy for years. It found that combined estrogen-plus-progestin therapy increased the risk of heart disease, stroke, blood clots, breast cancer, and dementia. However, those findings applied primarily to older women who started hormones well past menopause. Estrogen alone (in women who’d had hysterectomies) showed a more favorable profile, though it still raised the risk of stroke and blood clots.
The type of hormone and how you take it also matters. Oral estrogen passes through the liver first, which triggers the production of clotting factors. Transdermal estrogen, delivered through a patch or gel, bypasses the liver entirely. Multiple studies have confirmed the difference is real: oral estrogen roughly triples the risk of blood clots, while transdermal estrogen shows no significant increase. One large cohort study found that patch and gel users had a 19% lower incidence of clot-related events compared to women taking pills. For women with any existing risk factors for blood clots, transdermal delivery is the safer choice.
Common Side Effects
Both hormones can cause side effects, especially in the first few months. Breast tenderness, headaches, nausea, bloating, and mood changes are the most frequently reported. Some women experience fluid retention in the hands, feet, or lower legs. Irregular vaginal bleeding can occur as your body adjusts, particularly with combined therapy.
Progesterone, especially the oral form taken at bedtime, tends to cause drowsiness. For many women this is actually a benefit, since it doubles as a sleep aid. If drowsiness is a problem during the day, timing the dose at night usually resolves it.
Putting It Together
The decision tree is simpler than it might seem. If you have a uterus and want estrogen therapy for menopause symptoms, you need progesterone too. If you’ve had a hysterectomy, estrogen alone is typically sufficient. If you’re in perimenopause with sleep and mood complaints but few hot flashes, progesterone alone may be worth trying first. And if you’re considering any form of hormone therapy, starting within the first 10 years of menopause gives you the best balance of benefit and safety, with transdermal estrogen offering the lowest clot risk among delivery options.